OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
Ranga Dissanayake, Rheal A. Towner, Marya Ahmed
Cancers (2023) Vol. 15, Iss. 11, pp. 2906-2906
Open Access | Times Cited: 17
Ranga Dissanayake, Rheal A. Towner, Marya Ahmed
Cancers (2023) Vol. 15, Iss. 11, pp. 2906-2906
Open Access | Times Cited: 17
Showing 17 citing articles:
Polyphenol-Based Nanoparticles: A Promising Frontier for Enhanced Colorectal Cancer Treatment
Hicham Wahnou, Bertrand Liagre, Vincent Sol, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3826-3826
Open Access | Times Cited: 27
Hicham Wahnou, Bertrand Liagre, Vincent Sol, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3826-3826
Open Access | Times Cited: 27
Green synthesis, characterization, antioxidant, interaction with DNA/BSA, and investigation of cytotoxicity against MCF-7 cancer cells of zinc oxide nanoparticles using Hammada scoparia (Pomel) Iljin extract
Chaima Benine, Djahra Ali Boutlelis, Laiche Ammar Touhami, et al.
International Journal of Biological Macromolecules (2025), pp. 139709-139709
Closed Access | Times Cited: 1
Chaima Benine, Djahra Ali Boutlelis, Laiche Ammar Touhami, et al.
International Journal of Biological Macromolecules (2025), pp. 139709-139709
Closed Access | Times Cited: 1
Exploring the Potential of Nanoparticles in the Treatment of Breast Cancer: Current Applications and Future Directions
Puja Patel, Vadanasundari Vedarethinam, Maame A. Korsah, et al.
Applied Sciences (2024) Vol. 14, Iss. 5, pp. 1809-1809
Open Access | Times Cited: 4
Puja Patel, Vadanasundari Vedarethinam, Maame A. Korsah, et al.
Applied Sciences (2024) Vol. 14, Iss. 5, pp. 1809-1809
Open Access | Times Cited: 4
Metastasis and chemoresistance in breast cancer: Crucial function of ZEB1/2 proteins
Seyed Mohammad Doodmani, Majid Safari, Mohammadarian Akbari, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155838-155838
Closed Access
Seyed Mohammad Doodmani, Majid Safari, Mohammadarian Akbari, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155838-155838
Closed Access
Global trends and research hotspots in nanodrug delivery systems for breast cancer therapy: a bibliometric analysis (2013–2023)
Yang Li, Pingping Liu, Bo Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Yang Li, Pingping Liu, Bo Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions
Md Abdus Samad, Iftikhar Ahmad, Torki A. Zughaibi, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100268-100268
Open Access
Md Abdus Samad, Iftikhar Ahmad, Torki A. Zughaibi, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100268-100268
Open Access
Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression
Pei‐Jou Chua, Suet-Hui Ow, Cheng-Teng Ng, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Pei‐Jou Chua, Suet-Hui Ow, Cheng-Teng Ng, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer
Ibrahim Alradwan, Pei Zhi, Tian Zhang, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 661-674
Closed Access | Times Cited: 2
Ibrahim Alradwan, Pei Zhi, Tian Zhang, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 661-674
Closed Access | Times Cited: 2
Fabrication, Characterization and In Vitro Cell Cytotoxicity of ZnO Nanoparticles on MDA‐MB 231 Breast Cancer Cell Line
Ashok Kumar Janakiraman, Zi Yin Wong, Zenli Cheng, et al.
ChemistrySelect (2023) Vol. 8, Iss. 37
Closed Access | Times Cited: 6
Ashok Kumar Janakiraman, Zi Yin Wong, Zenli Cheng, et al.
ChemistrySelect (2023) Vol. 8, Iss. 37
Closed Access | Times Cited: 6
Comparison of clinicopathologic characteristics and survival outcomes of various subtypes of breast cancer
Vahid Zangouri, Souzan Soufizadeh Balaneji, Iman Deylami, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Vahid Zangouri, Souzan Soufizadeh Balaneji, Iman Deylami, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
An Insights of Bioactive Elements on Malignancy: Mechanistic Avenues
V. Sandhiya
International Journal of Pharmacognosy & Chinese Medicine (2024) Vol. 8, Iss. 1, pp. 1-12
Open Access | Times Cited: 1
V. Sandhiya
International Journal of Pharmacognosy & Chinese Medicine (2024) Vol. 8, Iss. 1, pp. 1-12
Open Access | Times Cited: 1
Identification of significant hub genes and pathways associated with metastatic breast cancer and tolerogenic dendritic cell via bioinformatics analysis
Kirstie Wong Chee Ching, Noor Fatmawati Mokhtar, Gee Jun Tye
Computers in Biology and Medicine (2024) Vol. 184, pp. 109396-109396
Closed Access | Times Cited: 1
Kirstie Wong Chee Ching, Noor Fatmawati Mokhtar, Gee Jun Tye
Computers in Biology and Medicine (2024) Vol. 184, pp. 109396-109396
Closed Access | Times Cited: 1
Transition metal dichalcogenide coated gold nanoshells for highly effective photothermal therapy
Saeed Bagheri, Mohsen Farokhnezhad, Mahdi Esmaeilzadeh
Physical Chemistry Chemical Physics (2023) Vol. 25, Iss. 48, pp. 33038-33047
Closed Access | Times Cited: 2
Saeed Bagheri, Mohsen Farokhnezhad, Mahdi Esmaeilzadeh
Physical Chemistry Chemical Physics (2023) Vol. 25, Iss. 48, pp. 33038-33047
Closed Access | Times Cited: 2
Long-term cadmium exposure induces epithelial-mesenchymal transition in breast cancer cells by activating CYP1B1-mediated glutamine metabolic reprogramming in BT474 cells and MMTV-Erbb2 mice
Jingdian Li, Peng Gao, Mingke Qin, et al.
The Science of The Total Environment (2024) Vol. 918, pp. 170773-170773
Closed Access
Jingdian Li, Peng Gao, Mingke Qin, et al.
The Science of The Total Environment (2024) Vol. 918, pp. 170773-170773
Closed Access
Unveiling the Link Between Breast Cancer Treatment and Osteoporosis: Implications for Anticancer Therapy and Bone Health
Bhawna Goel, Tarun Virmani, Vikas Jain, et al.
BioMed Research International (2024) Vol. 2024, Iss. 1
Open Access
Bhawna Goel, Tarun Virmani, Vikas Jain, et al.
BioMed Research International (2024) Vol. 2024, Iss. 1
Open Access
Special Issue on Cancer Smart Nanomedicine
Marina Pinheiro, Ammad Ahmad Farooqi
Cancers (2023) Vol. 15, Iss. 22, pp. 5344-5344
Open Access
Marina Pinheiro, Ammad Ahmad Farooqi
Cancers (2023) Vol. 15, Iss. 22, pp. 5344-5344
Open Access
Homologous recombination deficiency reflects the heterogeneity and monitoring treatment response for patients with breast cancer
Quanyi Long, Yunfei Wang, Hongjiang Li
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access
Quanyi Long, Yunfei Wang, Hongjiang Li
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access
